Wells Fargo & Company Sutro Biopharma, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 41,857 shares of STRO stock, worth $179,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,857

Previous 27,367 52.95%

Holding current value

$179,566

Previous $154,000 20.78%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.33 $42,310 - $77,231	14,490 Added 52.95%	41,857 $122,000
Q1 2024 May 10, 2024	BUY	$3.27 - $5.65 $13,714 - $23,696	4,194 Added 18.1%	27,367 $154,000
Q4 2023 Feb 09, 2024	BUY	$2.07 - $4.54 $7,567 - $16,598	3,656 Added 18.73%	23,173 $99,000
Q3 2023 Nov 13, 2023	SELL	$3.29 - $4.9 $26,510 - $39,484	-8,058 Reduced 29.22%	19,517 $67,000
Q2 2023 Aug 15, 2023	SELL	$4.25 - $5.88 $95,999 - $132,817	-22,588 Reduced 45.03%	27,575 $128,000
Q1 2023 May 12, 2023	BUY	$4.48 - $8.45 $199,239 - $375,796	44,473 Added 781.6%	50,163 $231,000
Q4 2022 Feb 13, 2023	BUY	$5.41 - $8.08 $23,652 - $35,325	4,372 Added 331.71%	5,690 $45,000
Q3 2022 Nov 14, 2022	SELL	$5.17 - $7.11 $7,413 - $10,195	-1,434 Reduced 52.11%	1,318 $8,000
Q2 2022 Aug 12, 2022	SELL	$3.41 - $8.95 $120,567 - $316,445	-35,357 Reduced 92.78%	2,752 $14,000
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $109,760 - $215,993	-14,108 Reduced 27.02%	38,109 $313,000
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $863,592 - $1.43 Million	-60,603 Reduced 53.72%	52,217 $777,000
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $461,651 - $612,070	-27,349 Reduced 19.51%	112,820 $2.13 Million
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $64,294 - $84,942	-3,566 Reduced 2.48%	140,169 $2.61 Million
Q1 2021 May 13, 2021	BUY	$20.29 - $27.54 $1.64 Million - $2.23 Million	80,989 Added 129.07%	143,735 $3.27 Million
Q4 2020 Feb 09, 2021	BUY	$10.16 - $23.98 $173,319 - $409,074	17,059 Added 37.34%	62,746 $1.36 Million
Q3 2020 Nov 05, 2020	BUY	$7.44 - $13.15 $111,689 - $197,407	15,012 Added 48.94%	45,687 $459,000
Q2 2020 Aug 13, 2020	BUY	$7.24 - $11.05 $66,702 - $101,803	9,213 Added 42.93%	30,675 $238,000
Q1 2020 May 14, 2020	BUY	$6.19 - $12.16 $132,849 - $260,977	21,462 New	21,462 $218,000

Others Institutions Holding STRO

# of Institutions

124

Shares Held

63M

Call Options Held

200

Put Options Held

27.6K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $224M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Sutro Biopharma, Inc. Transaction History